Professor Elio Riboli is Director of the School of Public Health at Imperial College London, rated one of the top two epidemiology and public health submissions to the UK’s Research Assessment Exercise (RAE) in 2009. He holds an M.D. degree (1977, State University of Milan), a Master of Public Health (1980, Milan) and a Master of Science in Epidemiology (1982, Harvard University). Professor Riboli is a Registered Physician (General Medical Council, UK, 2005) and an Honorary Fellow of the Royal College of Physicians (2008).
From 1983 to 2005 Professor Riboli was based at Lyon’s the International Agency for Research on Cancer (IARC), where he developed new research projects in the areas of nutrition, nutritional status and cancer. In 1989 he initiated the European Prospective Investigation into Cancer and Nutrition (EPIC), which sampled data from 500,000 subjects across 26 centres in ten countries. He was Head of the Nutrition and Hormones Group of IARC from 2004 to 2005.
Professor Riboli has co-authored over 310 peer-reviewed publications and over 100 book chapters and books and serves on editorial boards of major journals on nutrition, cancer and epidemiology.
In 2005 he joined Imperial College London as Professor of Cancer Epidemiology; in 2006 he was appointed Divisional Head of Epidemiology, Public Health and Primary Care, and became Director when the School of Public Health was established in January 2010.
et al., Nutrient-wide association study of 57 foods/nutrients and epithelial ovarian cancer in the EPIC study and the NLCS, American Journal of Clinical Nutrition, ISSN:1938-3207
Riboli E, Interaction of dietary and genetic factors influencing body iron status and risk of type 2 diabetes within the EPIC-InterAct Study.Gene-Haem iron interactions and type 2 diabetes, Diabetes Care, ISSN:0149-5992
et al., 2017, Physical activity, mediating factors and risk of colon cancer: insights into adiposity and circulating biomarkers from the EPIC cohort., Int J Epidemiol
et al., 2017, Chronic disease research in Europe and the need for integrated population cohorts, European Journal of Epidemiology, Vol:32, ISSN:0393-2990, Pages:741-749
et al., 2017, Circulating RANKL and RANKL/OPG and Breast Cancer Risk by ER and PR Subtype: Results from the EPIC Cohort, Cancer Prevention Research, Vol:10, ISSN:1940-6207, Pages:525-534